Supplementary section S3
Combination therapy protocol and experimental set up used for the study Table S3 . Sequence of the chemoradiation protocol used for the radiation experiments.
Supplementary section S4

Bliss Independence Criterion
One of the most commonly used models to study combined effects of substances in vivo and in vitro is the Bliss Independence Criterion as reference 1, 2 . The Bliss criterion for two toxic agents to have an additive effect is expressed by the following equation:
where is the fractional effect (between 0 and 1), and are the doses of two compounds in a combinational experiment. If the experimental effect is larger than the calculated value, the experimental result indicates a synergistic effect. If the experimental effect is smaller than the calculated value, the experimental result indicates an antagonistic effect. Otherwise, the effect is additive 1-3 . The Bliss equations are applicable to experimental data for single points and entire dose-response curves but the main assumption of the Bliss Independence Criterion is that the toxic agents act independently from one another The expected additive effect of IR GNP-RGD; CIS was calculated to be 0.82 ± 0.02 which also is within the range of the experimental effect of 0.84 ± 0.007. Since the difference of zero is within the propagated uncertainty range of the difference for both IR GNP-RGD-BLM and IR GNP-RGD; CIS, the calculated effect and the experimental effect can be concluded to agree. The triple combined effect of GNP-RGD; CIS and radiation both indicate an additive effect with the assumption that the chemotherapeutic (GNP-RGD; CIS) and the physical agent (radiation) is independent.
Supplementary section S5
Clinical relevance of the in vitro results
In the clinics, multiple dosages of chemotherapy and multiple dosages of radiation are generally prescribed to the patient and the schedule, dosage of treatment is different from patient to patient. The usage of GNP-RGD in combination with chemotherapeutic agents, radiation, and combined chemotherapeutic agents with radiation has shown statistically significant improvement in this study and the effectiveness (X) can become more apparent for multiple treatments. Assuming that each treatment is equally effective, and there is no cell proliferation between treatments, the survival following n treatments is given by , which is a concept introduced by Hill and Bristow 4 . In this case, X is the survival fraction (SF). The survival fraction post 10, and 20 treatments of the various permutations of GNP-RGD, chemo (CIS), and radiation and the percentage decrease of the condition pairs are summarized in Table S4 . As shown in Table S4 , small differences in survival can translate into large differences and therefore a larger significance during a course of multiple treatments 4 .
Supplementary section S6
Tumor control probability
The probability of tumour control can be estimated from the following equation:
Where 0 is the probability that a tumour will contain no survival stem cells, a is the average number of cells surviving 4 . To achieve tumour control, all tumour stem cells must be killed 4 . Tumour stem cells are referred to the limited proportion of tumour cells with the capacity for cell proliferation 5 . Cells from human tumours have been found to be able to generate colonies in adequate nutrient environment, however, the proportion of cells that generate colonies have been found to be low (less than 1 percent) which suggests a low proportion of tumour stem cells 5 .
A small difference in survival can translate into large differences over multiple treatments and that can also lead to a significant difference in tumour control probability. An example to show the difference in tumour control probability is shown in Table S5 . 
